Analytical Data
-
基因名
TIM-4/TIMD-4
- Application
-
别名
TIM4; T-cell membrane protein 4; T-cell immunoglobulin mucin receptor 4
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96H15
-
表达区间
Glu25~Gln314
-
分子量
40kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TIM-4 (T cell immunoglobulin and mucin domain-containing protein 4) is a member of the TIM family, which plays a crucial role in immune regulation. TIM-4 is primarily expressed on antigen-presenting cells, such as dendritic cells and macrophages, where it interacts with TIM-1 on T cells, thereby influencing T cell activation and differentiation. This interaction can have significant implications for immune responses, particularly in contexts such as allergy, autoimmunity, and cancer. The study of recombinant TIM-4 and its interactions with TIM-1 is essential for understanding the mechanisms underlying immune regulation and for developing potential therapeutic strategies targeting TIM-4. Research has shown that TIM-4 can modulate T cell responses, enhancing or inhibiting activation depending on the context, making it a key player in immunological balance. Additionally, recombinant TIM-4 proteins have been explored for their potential as biomarkers and therapeutic targets in various diseases. As the understanding of TIM-4/TIM-1 signaling pathways advances, it opens new avenues for manipulating immune responses, offering hope for innovative treatments in immune-mediated diseases and improving the efficacy of cancer immunotherapies.
